Silverfin false false 31/03/2024 01/04/2023 31/03/2024 Dr M Carter 01/09/2020 Dr M Danielsen 01/09/2020 Mrs W George 01/04/2022 Dr D Haghani 01/09/2020 Mr S Holby 01/09/2020 Dr M Sharp 01/09/2020 Dr J Smith 01/09/2020 Dr P Trevail 01/09/2020 Dr A Watson 01/09/2020 Dr M Whiteley 01/09/2020 Mr S Wordley 01/04/2022 28 October 2024 The principal activity of the company during the financial year was that of the provision of medical services. 12851116 2024-03-31 12851116 bus:Director1 2024-03-31 12851116 bus:Director2 2024-03-31 12851116 bus:Director3 2024-03-31 12851116 bus:Director4 2024-03-31 12851116 bus:Director5 2024-03-31 12851116 bus:Director6 2024-03-31 12851116 bus:Director7 2024-03-31 12851116 bus:Director8 2024-03-31 12851116 bus:Director9 2024-03-31 12851116 bus:Director10 2024-03-31 12851116 bus:Director11 2024-03-31 12851116 2023-03-31 12851116 core:CurrentFinancialInstruments 2024-03-31 12851116 core:CurrentFinancialInstruments 2023-03-31 12851116 core:ShareCapital 2024-03-31 12851116 core:ShareCapital 2023-03-31 12851116 core:RetainedEarningsAccumulatedLosses 2024-03-31 12851116 core:RetainedEarningsAccumulatedLosses 2023-03-31 12851116 core:OtherPropertyPlantEquipment 2023-03-31 12851116 core:OtherPropertyPlantEquipment 2024-03-31 12851116 bus:OrdinaryShareClass1 2024-03-31 12851116 bus:OrdinaryShareClass2 2024-03-31 12851116 bus:OrdinaryShareClass3 2024-03-31 12851116 bus:OrdinaryShareClass4 2024-03-31 12851116 bus:OrdinaryShareClass5 2024-03-31 12851116 bus:OtherShareClass1 2024-03-31 12851116 bus:OtherShareClass2 2024-03-31 12851116 bus:OtherShareClass3 2024-03-31 12851116 bus:OtherShareClass4 2024-03-31 12851116 2023-04-01 2024-03-31 12851116 bus:FilletedAccounts 2023-04-01 2024-03-31 12851116 bus:SmallEntities 2023-04-01 2024-03-31 12851116 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 12851116 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12851116 bus:Director1 2023-04-01 2024-03-31 12851116 bus:Director2 2023-04-01 2024-03-31 12851116 bus:Director3 2023-04-01 2024-03-31 12851116 bus:Director4 2023-04-01 2024-03-31 12851116 bus:Director5 2023-04-01 2024-03-31 12851116 bus:Director6 2023-04-01 2024-03-31 12851116 bus:Director7 2023-04-01 2024-03-31 12851116 bus:Director8 2023-04-01 2024-03-31 12851116 bus:Director9 2023-04-01 2024-03-31 12851116 bus:Director10 2023-04-01 2024-03-31 12851116 bus:Director11 2023-04-01 2024-03-31 12851116 core:OtherPropertyPlantEquipment core:TopRangeValue 2023-04-01 2024-03-31 12851116 2022-04-01 2023-03-31 12851116 core:OtherPropertyPlantEquipment 2023-04-01 2024-03-31 12851116 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12851116 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 12851116 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 12851116 bus:OrdinaryShareClass2 2022-04-01 2023-03-31 12851116 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 12851116 bus:OrdinaryShareClass3 2022-04-01 2023-03-31 12851116 bus:OrdinaryShareClass4 2023-04-01 2024-03-31 12851116 bus:OrdinaryShareClass4 2022-04-01 2023-03-31 12851116 bus:OrdinaryShareClass5 2023-04-01 2024-03-31 12851116 bus:OrdinaryShareClass5 2022-04-01 2023-03-31 12851116 bus:OtherShareClass1 2023-04-01 2024-03-31 12851116 bus:OtherShareClass1 2022-04-01 2023-03-31 12851116 bus:OtherShareClass2 2023-04-01 2024-03-31 12851116 bus:OtherShareClass2 2022-04-01 2023-03-31 12851116 bus:OtherShareClass3 2023-04-01 2024-03-31 12851116 bus:OtherShareClass3 2022-04-01 2023-03-31 12851116 bus:OtherShareClass4 2023-04-01 2024-03-31 12851116 bus:OtherShareClass4 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12851116 (England and Wales)

CARN TO COAST HEALTH LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2024
Pages for filing with the registrar

CARN TO COAST HEALTH LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2024

Contents

CARN TO COAST HEALTH LIMITED

BALANCE SHEET

As at 31 March 2024
CARN TO COAST HEALTH LIMITED

BALANCE SHEET (continued)

As at 31 March 2024
Note 2024 2023
£ £
Restated - note 2
Fixed assets
Tangible assets 5 6,118 1,370
6,118 1,370
Current assets
Debtors 6 15,903 742
Cash at bank and in hand 316,646 358,022
332,549 358,764
Creditors: amounts falling due within one year 7 ( 30,605) ( 40,643)
Net current assets 301,944 318,121
Total assets less current liabilities 308,062 319,491
Net assets 308,062 319,491
Capital and reserves
Called-up share capital 8 753 753
Profit and loss account 307,309 318,738
Total shareholders' funds 308,062 319,491

For the financial year ending 31 March 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Carn to Coast Health Limited (registered number: 12851116) were approved and authorised for issue by the Board of Directors on 28 October 2024. They were signed on its behalf by:

Dr P Trevail
Director
CARN TO COAST HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
CARN TO COAST HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Carn to Coast Health Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Goodwood House, Blackbrook Park Avenue, Taunton, TA1 2PX, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date. Tax is recognised in the profit and loss account, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date that are expected to apply when the timing differences reverse. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit. Deferred tax liabilities are presented within provisions for liabilities on the balance sheet.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in other operating income over the period in which the related costs are recognised, and timing differences are presented as other debtors or deferred income within the balance sheet. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

2. Prior year adjustment

The accounts to 31 March 2023 have been restated to include the ordinary A, B, C, D, E, F, G, H, I, J, K shares that were in issue but not included in the accounts. 10 of these shares were in issue from 22 November 2021 and 1 further share in issue from 1 April 2022.

As previously reported Adjustment As restated
Year ended 31 March 2023 £ £ £
Share capital 742 11 753
Creditors 40,654 (11) 40,643

3. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 11 11

4. Dividends on equity shares

2024 2023
£ £
Amounts recognised as distributions to equity holders in the financial year:
Interim dividend for the financial year ended 31 March 2024 of £14.608234 (2023: £29.216467) per ordinary share 11,000 22,000

5. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2023 1,827 1,827
Additions 6,752 6,752
At 31 March 2024 8,579 8,579
Accumulated depreciation
At 01 April 2023 457 457
Charge for the financial year 2,004 2,004
At 31 March 2024 2,461 2,461
Net book value
At 31 March 2024 6,118 6,118
At 31 March 2023 1,370 1,370

6. Debtors

2024 2023
£ £
Trade debtors 15,903 0
Other debtors 0 742
15,903 742

7. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 12,238 0
Accruals and deferred income 3,312 8,065
Taxation and social security 0 28,781
Other creditors 15,055 3,797
30,605 40,643

8. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
1 Ordinary A share of £ 1.00 1 1
1 Ordinary B share of £ 1.00 1 1
1 Ordinary C share of £ 1.00 1 1
1 Ordinary D share of £ 1.00 1 1
1 Ordinary E share of £ 1.00 1 1
1 Ordinary F share of £ 1.00 1 1
1 Ordinary G share of £ 1.00 1 1
1 Ordinary H share of £ 1.00 1 1
1 Ordinary I share of £ 1.00 1 1
1 Ordinary J share of £ 1.00 1 1
1 Ordinary K share of £ 1.00 1 1
742 Ordinary shares of £ 1.00 each 742 742
753 753